Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Tax harvesting to lower capital gains automates selling decisions to reduce taxes while maintaining portfolio goals.
25,625 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Axsome's 2025 earnings season is shaping up as a pivotal moment for investors. This article breaks down what to expec...
Geopolitical shocks echoed through crypto flows as Iranian exchanges saw a dramatic outflow spike totaling $10.3 mill...
A new leadership playbook is on the table at Target. This article breaks down five actionable takeaways from the late...
Disney names Josh D’Amaro as CEO, effective March 18, 2026, ending a long succession saga. The new leader brings a un...
Energy leaders convene amid a tightening mix of growth and risk. AI-driven demand and geopolitical tensions push pric...
Bitcoin faces a pivotal crossroad as the 4-year cycle motif intersects ETF-driven demand and the lingering effects of...
Analysts project NVIDIA’s free cash flow to climb sharply as AI deployments accelerate, potentially changing how inve...
Discover how NVIDIA stands at the center of the AI revolution, what to watch in its business, and how to assess the i...
LadderUp Housing secures a multi-year investment from the Richard King Mellon Foundation to broaden its rent-to-homeo...
XRP trades near a 15-week low around $1.30 as ETF demand remains steady while on-chain withdrawals intensify, signali...
Neura secures strategic funding and announces key partnerships to build Emotional AI with memory that persists across...